대한부인종양학회

최신 논문

총 게시글 : 216

PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti-PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial 2026-09-30 VIEW : 3
First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma 2026-09-30 VIEW : 1
Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0 2026-09-30 VIEW : 4
Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical Trial 2026-09-30 VIEW : 3
Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study 2026-09-30 VIEW : 2
Neoadjuvant tislelizumab (anti-PD-1 antibody) plus chemotherapy in patients with advanced epithelial ovarian cancer: the exploratory NAIVE trial 2026-09-30 VIEW : 2
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study 2026-09-30 VIEW : 2
Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double- 2026-09-30 VIEW : 1
Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study 2026-09-30 VIEW : 1
Iparomlimab and tuvonralimab in previously treated patients with cervical cancer 2026-09-30 VIEW : 1
Pembrolizumab Plus Chemotherapy for Cervical Cancer: An Exploratory Analysis of the KEYNOTE-826 Randomized Clinical Trial 2026-09-30 VIEW : 3
Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy 2026-09-30 VIEW : 2
Surgical window of opportunity clinical trial of abemaciclib and letrozole for endometrioid adenocarcinoma of the endometrium 2026-09-30 VIEW : 1
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK 2026-09-30 VIEW : 1
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer 2026-09-30 VIEW : 1

1
2
3
4
5
6
7
8
9
10
...
14
15